News & AnalysisTranscarent scores $58m Series BSilicon Valley-based Transcarent, a health experience company, has raised $58 million in Series B funding.ByIris Dorbian10 June 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs